Fiche centre
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou — China
Essais liés2clinical trials
VilleHangzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07752264
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Equecabtagene Autoleucel Injection (Eque-cel) | Myopathies | Phase 1/2 | NCT07752264 | A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | NOT_YET_RECRUITING |
| Tizanidine Hydrochloride | Migraine | Phase 3 | NCT05484349 | TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME） | UNKNOWN |